ArticleBlood advances2024

CBFA2T3::GLIS2 pediatric acute megakaryoblastic leukemia is sensitive to BCL-XL inhibition by navitoclax and DT2216.

Verena Gress et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.